Original contributionsValidation of venous pCO2 to screen for arterial hypercarbia in patients with chronic obstructive airways disease
Introduction
Management of acute exacerbations of chronic obstructive pulmonary disease (COPD) is challenging. Blood gas analysis, in particular measurement of pCO2 for the detection of CO2 retention, is useful in guiding oxygen therapy and the need for ventilatory support. But arterial blood gas samples are not without problems. They are painful and have a small incidence of complications including local hematoma, infection, occlusion and embolization with consequent ischemic injury to the digits. There is also a risk of needlestick injury to health care workers associated with an additional vascular puncture.
Previous research has shown excellent agreement between pH measured on arterial and venous samples and good agreement between oxygen saturation measured by pulse oximeter and by arterial blood gas (ABG) (1, 2, 3, 4, 5, 6, 7, 8, 9). We have previously reported a derivation study exploring a potential screening cut-off for pvCO2 in the detection of arterial hypercarbia (10). That study showed that a pvCO2 screening cutoff of > 45 mm Hg was 100% sensitive in detecting cases of arterial hypercarbia with a specificity of 51.7%. The objective of this study was the validation of that screening cut-off.
Section snippets
Methods
This prospective study was conducted in the Emergency Department (ED) of Western Hospital, a 250-bed community teaching hospital in Melbourne, Australia. The ED has an annual census of approximately 32,000 adult patients.
Patients were eligible for entry into the study if they presented with an acute exacerbation of COPD (judged and documented by the treating clinician) and were deemed by the treating doctor to require an ABG analysis to determine their ventilatory status. Confirmation of COPD
Results
There were 112 patients enrolled in the study, of whom 107 had complete data for analysis. The median age of patients was 73 years. The median paCO2 was 45 mm Hg (range 24–90 mm Hg). Forty-three patients (40%) had arterial hypercarbia (range of 51–90 mm Hg, median 60 mm Hg). Agreement between arterial and venous pCO2 was poor with a bias of 6 mm Hg and 95% limits of agreement of −14 to +26 mm Hg.
All cases of arterial hypercarbia were detected by the screening cut-off (sensitivity 100%; 43/43;
Discussion
ABG analysis is the standard method for obtaining an estimation of pCO2 in the clinical evaluation of patients suffering exacerbations of COPD. ABGs, however, are unpleasant and carry a small risk of complications for both patients and staff. If there was an alternative method of obtaining this information without an additional puncture, there would be potential benefits for staff and patients.
Although several studies have shown good correlation between arterial and venous pCO2, this study and
Conclusion
Venous CO2 can be used as a screening test for arterial hypercarbia and, if employed, can potentially reduce the requirement for ABG sampling.
Acknowledgments
The investigators would like to thank Denise Green, Darren Gaut and Lyndal Morgan (nurse educators) for their role in promoting the study and the nursing and medical staff of the Emergency Department for their participation.
References (12)
- et al.
Choice of blood for acid-base studies
Lancet
(1963) - et al.
Use of venous blood for pH and carbon dioxide studies especially in respiratory failure and during anaesthesia
Lancet
(1959) - et al.
How accurate are pulse oximeters in patients with acute exacerbations of chronic obstructive airways disease?
Respir Med
(2001) - et al.
Venous pCO2 and pH can be used to screen for significant hypercarbia in emergency patients with acute respiratory disease
J Emerg Med
(2002) Comparisons of pH in human arterial, venous and capillary blood
Am J Clin Pathol
(1959)Venous or arterial blood gas measurement
JAMA
(1971)
Cited by (0)
Original Contributions is coordinated by John Marx, MD, of Carolinas Medical Center, Charlotte, North Carolina